BDBM50153563 3-Benzo[1,3]dioxol-5-yl-4-[1-(4-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl-butyryl)-piperidin-4-yl]-butyric acid::CHEMBL187174

SMILES OC(=O)CC(CC1CCN(CC1)C(=O)CCCc1ccc2CCCNc2n1)c1ccc2OCOc2c1

InChI Key InChIKey=RPMQJDIFUVQKPJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50153563   

TargetIntegrin alpha-V/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50153563(3-Benzo[1,3]dioxol-5-yl-4-[1-(4-5,6,7,8-tetrahydro...)
Affinity DataIC50: 20.6nMAssay Description:Inhibition of human vitronectin binding to immobilized Alpha v beta-3More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50153563(3-Benzo[1,3]dioxol-5-yl-4-[1-(4-5,6,7,8-tetrahydro...)
Affinity DataIC50: 4.26E+3nMAssay Description:Inhibition of human Biotinylated Fg binding to immobilized Alpha II beta-3More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed